Literature DB >> 4043049

Creatine kinase MB and citrate synthase in type I and type II muscle fibres in trained and untrained men.

E Jansson, C Sylvén.   

Abstract

Total creatine kinase (CK), creatine kinase MB (CK-MB) and citrate synthase (CS) were determined in isolated and pooled type I and type II skeletal muscle fibres. Determinations were made on biopsies from 3 sedentary men, 3 junior cyclists and 2 elite cyclists. CS and CK-MB activities were higher in the trained groups in both fibre types. The total CK activity was not related to training status, although it was lower in type I fibres than in type II fibres (p less than 0.05). The reverse relation was observed for CS and CK-MB activities (p less than 0.01). The ratio of type I/type II for CS was not related to training status, while the corresponding ratio for CK-MB increased with a greater degree of endurance training. For a given increase in CS activity, the increase in CK-MB activity was greater in type I fibres than in type II fibres (p less than 0.01). Thus, with endurance training there seems to be a specific adaptation for CK-MB, particularly in type I fibres.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4043049     DOI: 10.1007/bf02335931

Source DB:  PubMed          Journal:  Eur J Appl Physiol Occup Physiol        ISSN: 0301-5548


  7 in total

1.  Metabolic characteristics of fibre types in human skeletal muscle.

Authors:  B Essén; E Jansson; J Henriksson; A W Taylor; B Saltin
Journal:  Acta Physiol Scand       Date:  1975-10

2.  Separation of tissue and serum creatine kinase isoenzymes by ion-exchange column chromatography.

Authors:  D W Mercer
Journal:  Clin Chem       Date:  1974       Impact factor: 8.327

Review 3.  Transport of energy in muscle: the phosphorylcreatine shuttle.

Authors:  S P Bessman; P J Geiger
Journal:  Science       Date:  1981-01-30       Impact factor: 47.728

4.  Separation of creatine kinase isoenzymes in serum by ion-exchange column chromatography (Mercer's method, modified to increase sensitivity).

Authors:  D A Nealon; A R Henderson
Journal:  Clin Chem       Date:  1975-03       Impact factor: 8.327

5.  Human creatine kinase. Isoenzymes and logistics of energy distribution.

Authors:  C Sylvén; E Jansson; A Kallner; K Böök
Journal:  Scand J Clin Lab Invest       Date:  1984-11       Impact factor: 1.713

6.  Human myocardial and skeletal muscle enzyme activities: creatine kinase and its isozyme MB as related to citrate synthase and muscle fibre types.

Authors:  C Sylvén; E Jansson; C Olin
Journal:  Clin Physiol       Date:  1983-10

7.  Muscle adaptation to extreme endurance training in man.

Authors:  E Jansson; L Kaijser
Journal:  Acta Physiol Scand       Date:  1977-07
  7 in total
  6 in total

1.  Profiles of creatine kinase isoenzyme compositions in single muscle fibres of different types.

Authors:  K Yamashita; T Yoshioka
Journal:  J Muscle Res Cell Motil       Date:  1991-02       Impact factor: 2.698

Review 2.  Exercise-induced muscle damage: mechanism, assessment and nutritional factors to accelerate recovery.

Authors:  I Markus; K Constantini; J R Hoffman; S Bartolomei; Yftach Gepner
Journal:  Eur J Appl Physiol       Date:  2021-01-08       Impact factor: 3.078

Review 3.  Effect of exercise on serum enzyme activities in humans.

Authors:  T D Noakes
Journal:  Sports Med       Date:  1987 Jul-Aug       Impact factor: 11.136

4.  Muscle ubiquinone in male effort angina patients.

Authors:  J Karlsson; L Lin; S Gunnes; C Sylvén; H Aström
Journal:  Mol Cell Biochem       Date:  1996-03-23       Impact factor: 3.396

Review 5.  Skeletal and Respiratory Muscle Dysfunctions in Pulmonary Arterial Hypertension.

Authors:  Marianne Riou; Mégane Pizzimenti; Irina Enache; Anne Charloux; Mathieu Canuet; Emmanuel Andres; Samy Talha; Alain Meyer; Bernard Geny
Journal:  J Clin Med       Date:  2020-02-03       Impact factor: 4.241

6.  Phosphatase orphan 1 inhibits myoblast proliferation and promotes myogenic differentiation.

Authors:  Ying Peng; Feng Yue; Jingjuan Chen; Wei Xia; Kuilong Huang; Gongshe Yang; Shihuan Kuang
Journal:  FASEB J       Date:  2020-11-02       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.